178 related articles for article (PubMed ID: 11104672)
21. A complex RNA-cleaving DNAzyme that can efficiently cleave a pyrimidine-pyrimidine junction.
Lam JC; Withers JB; Li Y
J Mol Biol; 2010 Jul; 400(4):689-701. PubMed ID: 20630470
[TBL] [Abstract][Full Text] [Related]
22. Specific cleavage of a target RNA from HIV-1 by mammalian tRNA 3' processing endoribonuclease directed by an RNA heptamer.
Nashimoto M; Kaspar R
Nucleic Acids Symp Ser; 1997; (36):22-5. PubMed ID: 9478195
[TBL] [Abstract][Full Text] [Related]
23. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
[TBL] [Abstract][Full Text] [Related]
24. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
[TBL] [Abstract][Full Text] [Related]
25. Target-site selection for the 10-23 DNAzyme.
Cairns MJ; Sun LQ
Methods Mol Biol; 2004; 252():267-77. PubMed ID: 15017056
[TBL] [Abstract][Full Text] [Related]
26. Suppression of hepatitis C virus genome replication in cells with RNA-cleaving DNA enzymes and short-hairpin RNA.
Lee B; Kim KB; Oh S; Choi JS; Park JS; Min DH; Kim DE
Oligonucleotides; 2010 Dec; 20(6):285-96. PubMed ID: 20863235
[TBL] [Abstract][Full Text] [Related]
27. Sequence-specific cleavage activities of DNA enzymes targeted against HIV-1 Gag and Nef regions.
Dash BC; Banerjea AC
Oligonucleotides; 2004; 14(1):41-7. PubMed ID: 15104895
[TBL] [Abstract][Full Text] [Related]
28. An efficient RNA-cleaving DNA enzyme that synchronizes catalysis with fluorescence signaling.
Mei SH; Liu Z; Brennan JD; Li Y
J Am Chem Soc; 2003 Jan; 125(2):412-20. PubMed ID: 12517153
[TBL] [Abstract][Full Text] [Related]
29. Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes.
Trepanier J; Tanner JE; Momparler RL; Le ON; Alvarez F; Alfieri C
J Viral Hepat; 2006 Feb; 13(2):131-8. PubMed ID: 16436131
[TBL] [Abstract][Full Text] [Related]
30. Highly active low magnesium hammerhead ribozyme.
Fedoruk-Wyszomirska A; Szymański M; Wyszko E; Barciszewska MZ; Barciszewski J
J Biochem; 2009 Apr; 145(4):451-9. PubMed ID: 19124457
[TBL] [Abstract][Full Text] [Related]
31. DNA enzyme generated by a novel single-stranded DNA expression vector inhibits expression of the essential bacterial cell division gene ftsZ.
Tan XX; Rose K; Margolin W; Chen Y
Biochemistry; 2004 Feb; 43(4):1111-7. PubMed ID: 14744157
[TBL] [Abstract][Full Text] [Related]
32. Quantitative analysis of a RNA-cleaving DNA catalyst obtained via in vitro selection.
Carrigan MA; Ricardo A; Ang DN; Benner SA
Biochemistry; 2004 Sep; 43(36):11446-59. PubMed ID: 15350131
[TBL] [Abstract][Full Text] [Related]
33. Selection and characterization of peptides specifically binding to HIV-1 psi (psi) RNA.
Park MY; Kwon J; Lee S; You J; Myung H
Virus Res; 2004 Nov; 106(1):77-81. PubMed ID: 15522450
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
Bramlage B; Luzi E; Eckstein F
Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
[TBL] [Abstract][Full Text] [Related]
35. The T12I mutation within the SP1 region of Gag restricts packaging of spliced viral RNA into human immunodeficiency virus type 1 with mutated RNA packaging signals and mutated nucleocapsid sequence.
Roy BB; Russell RS; Turner D; Liang C
Virology; 2006 Jan; 344(2):304-14. PubMed ID: 16226779
[TBL] [Abstract][Full Text] [Related]
36. Rational and combinatorial strategies for designing oligonucleotides targeted to RNA structures.
Toulmé JJ; Le Tinévez R; Boiziau C; Dausse E
Nucleic Acids Symp Ser; 1997; (36):39-41. PubMed ID: 9478200
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 gag expression is quantitatively dependent on the ratio of native and optimized codons.
Kofman A; Graf M; Bojak A; Deml L; Bieler K; Kharazova A; Wolf H; Wagner R
Tsitologiia; 2003; 45(1):86-93. PubMed ID: 12683241
[TBL] [Abstract][Full Text] [Related]
38. Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression.
Unwalla H; Banerjea AC
Antiviral Res; 2001 Aug; 51(2):127-39. PubMed ID: 11431037
[TBL] [Abstract][Full Text] [Related]
39. Characterization of an RNA-cleaving deoxyribozyme with optimal activity at pH 5.
Kandadai SA; Mok WW; Ali MM; Li Y
Biochemistry; 2009 Aug; 48(31):7383-91. PubMed ID: 19583262
[TBL] [Abstract][Full Text] [Related]
40. Dinucleotide junction cleavage versatility of 8-17 deoxyribozyme.
Cruz RP; Withers JB; Li Y
Chem Biol; 2004 Jan; 11(1):57-67. PubMed ID: 15112995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
